Results
|
61.
|
|
|
62.
|
|
|
63.
|
|
|
64.
|
|
|
65.
|
|
|
66.
|
|
|
67.
|
|
|
68.
|
|
|
69.
|
A randomized, open-label, multicenter, phase II study evaluating the efficacy and safety of BTH1677 (1,3-1,6 beta glucan; Imprime PGG) in combination with cetuximab and chemotherapy in patients with advanced non-small cell lung cancer. [electronic resource] by
- Thomas, M
- Sadjadian, P
- Kollmeier, J
- Lowe, J
- Mattson, P
- Trout, J R
- Gargano, M
- Patchen, M L
- Walsh, R
- Beliveau, M
- Marier, J F
- Bose, N
- Gorden, K
- Schneller, F
Producer: 20180321
In:
Investigational new drugs vol. 35
Availability: No items available.
|